Inventor · disambiguated record
Michael Kassiou
Also filed as: KASSIOU MICHAEL
12 granted patents·9 pending applications·82 citations·filing 1996–2024
88Inventor score
Files withUNIV SYDNEY10Kinoxis Therapeutics Pty Ltd6KASSIOU MICHAEL2US HEALTH2Kinoxis Therapeutics Pyt Ltd1
Top patents by PatentIndex Score
21 records- 0189US11890287B2Therapeutic compounds and compositions for treating social disorders and substance use disordersKinoxis Therapeutics Pty Ltd·Filed 2021·Granted Feb 6, 2024·2 cites·18 claims
- 0285US11033555B2Therapeutic compounds and compositions for treating social disorders and substance use disordersKinoxis Therapeutics Pty Ltd·Filed 2016·Granted Jun 15, 2021·3 cites·20 claims
- 0382US10807931B2Synthesis of phytocannabinoids including a decarboxylation stepUNIV SYDNEY·Filed 2018·Granted Oct 20, 2020·3 cites·17 claims
- 0481US5969144ARadiolabeled pyridyl-7-azabicyclo[2,2,1]heptanesUS HEALTH·Filed 1997·Granted Oct 19, 1999·60 cites·13 claims
- 0580US12458648B2Therapeutic compounds and compositions for treating social disorders and substance use disordersKinoxis Therapeutics Pty Ltd·Filed 2023·Granted Nov 4, 2025·0 cites·23 claims
- 0677US2024182419A1Anti-cancer compoundsUNIV SYDNEY·Filed 2024·Application pending·0 cites
- 0775US11939296B2Anti-cancer compoundsUNIV SYDNEY·Filed 2022·Granted Mar 26, 2024·0 cites·16 claims
- 0868US11472774B2Anti-cancer compoundsUNIV SYDNEY·Filed 2019·Granted Oct 18, 2022·0 cites·11 claims
- 0967US10745355B2Anti-cancer compoundsUNIV SYDNEY·Filed 2016·Granted Aug 18, 2020·2 cites·14 claims
- 1062US2023330103A1Non-peptide oxytocin receptor agonistsKinoxis Therapeutics Pty Ltd·Filed 2022·Application pending·0 cites
- 1160US11491165B2Non-peptide oxytocin receptor agonistsKinoxis Therapeutics Pty Ltd·Filed 2019·Granted Nov 8, 2022·0 cites·16 claims
- 1259US8492379B2Translocator protein ligandsKASSIOU MICHAEL·Filed 2008·Granted Jul 23, 2013·1 cites·6 claims
- 1352US2011142757A1Novel compounds and their uses in diagnosisUNIV SYDNEY·Filed 2009·Application pending·0 cites
- 1451US2009311176A12-Arylpyrazolo[L,5-Alpha] Pyrimidin-3-YL Acetamide Derivatives as Ligands for Translocator Protein (18 Kda)UNIV SYDNEY·Filed 2007·Application pending·0 cites
- 1548US5726189AMethod for imaging nicotinic acetylcholinergic receptors in the brain using radiolabeled pyridyl-7-azabicyclo 2.2.1!heptanesUS HEALTH·Filed 1996·Granted Mar 10, 1998·11 cites·22 claims
- 1642US2024067654A1Oxytocin receptor modulatorsKinoxis Therapeutics Pyt Ltd·Filed 2021·Application pending·0 cites
- 1742US2013224114A1Translocator Protein LigandsUNIV SYDNEY·Filed 2013·Application pending·0 cites
- 1841US2021163438A1Synthesis of phytocannabinoids including a demethylation stepUNIV SYDNEY·Filed 2018·Application pending·0 cites
- 1940US11414459B2Metabolite inspired selective oxytocin receptor agonistsKinoxis Therapeutics Pty Ltd·Filed 2018·Granted Aug 16, 2022·0 cites·6 claims
- 2039US2012189548A12-arylpyrazolo[l,5-alpha]pyrimidin-3-yl acetamide derivatives as ligands for translocator protein (18 kda)KASSIOU MICHAEL·Filed 2012·Application pending·0 cites
- 2138US2021323910A1Adamantanyl-substituted benzamide compounds and their use as p2x7 receptor antagonistsUNIV SYDNEY·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael Kassiou files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →